The management of patients with severe respiratory infections is becoming increasingly complex, with decisions around empiric antimicrobial therapy often leading to over- or under-treatment. Either scenario can negatively impact patient outcomes, potentially leading to an increase in mortality and long-term spread of antimicrobial resistance (AMR).
The clinical case below offers insights into how rapid diagnostic testing methods can provide actionable results that aid in treatment decisions and patient management associated with pneumonia in critical care settings.
Check back monthly for new clinical case content!
Global bioMérieux Solutions
The BioFire® FilmArray® Pneumonia (PN) Panel delivers fast, accurate pathogen identification in about one hour ― enabling quicker decisions on appropriate patient therapy and management.